when you peel the veneer away, they are enablers, persons of interest, co-conspirators. .
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. .
OFF DEAL
218 Used Today
OFF DEAL
181 Used Today